Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
American journal of translational research(2022)
Abstract
In the EGFR signaling pathway, ADOLA boosted the proliferation and cisplatin resistance of GC cells, making it a viable GC therapeutic target.
MoreTranslated text
Key words
ALDOA,EGFR,cisplatin resistance,gastric cancer,proliferation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined